胰十二指肠切除术与全胰切除术治疗胰头腺癌的肿瘤学结局比较
该研究基于SEER数据库1988至2016年非转移性胰头腺癌患者,比较胰十二指肠切除术(PD)与全胰切除术(TP)的早期死亡与长期生存。共纳入4748例(TP 743例,PD 4005例),倾向性评分匹配后TP 740例与PD 1479例比较,两组30天死亡率(3.5% vs. 2.7%,p=0.290)和90天死亡率(9.9% vs. 8%,p=0.135)无差异,且TP与PD生存相当。结论认为在肿瘤学合适的选择性患者中,TP可与PD获得相似的早期死亡和长期生存。
要点
- 匹配后TP与PD的30天死亡率(3.5% vs. 2.7%)和90天死亡率(9.9% vs. 8%)均无统计学差异。
- TP与PD的肿瘤特异性生存相当,排除30天和90天内死亡患者后结论不变。
- 肿瘤大小、肿瘤分期、N分期、化疗和放疗是显著预后因素。
核心结论
- 对于非转移性胰头腺癌,PD与TP具有相似的早期死亡率和长期生存。
- 在肿瘤学合适的选择性患者中,TP可作为手术选择。
研究设计与样本
- 基于SEER数据库1988至2016年非转移性胰头腺癌患者的回顾性队列研究。
- 共纳入4748例,其中TP 743例、PD 4005例;采用倾向性评分匹配平衡组间协变量。
- 主要终点为肿瘤特异性生存(CSS)。
主要发现
- 匹配后TP组740例与PD组1479例比较,30天死亡率3.5% vs. 2.7%(p=0.290),90天死亡率9.9% vs. 8%(p=0.135)。
- TP与PD的生存相当,排除30天和90天内死亡患者前后结论一致。
- 多因素分析显示肿瘤大小、肿瘤分期、N分期、化疗和放疗是显著预后因素。
临床怎么用
- 在肿瘤学合适的选择性胰头腺癌患者中,可考虑全胰切除术。
- 决策时需综合评估肿瘤大小、分期、N分期及放化疗等预后因素。
局限性
- 回顾性数据库研究,存在选择偏倚可能。
- 倾向性评分匹配仅能平衡已测量协变量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pancreatoduodenectomy (PD) and total pancreatectomy (TP) are two surgical methods to treat patients with pancreatic head adenocarcinoma (PHAC). However, the oncologic outcomes of TP for PHAC remain controversial. In this study, we compared early mortality and long-term survival patients undergoing TP and those with PD. METHODS: All patients diagnosed with non-metastatic PHAC who underwent PD or TP from 1988 to 2016 were retrieved from the Surveillance, Epidemiology, and End Results database. Propensity score matching (PSM) was used to balance the inter-group covariates. Cancer-specific survival (CSS) was the primary endpoint. RESULTS: A total of 4748 patients (743 TP and 4005 PD) were included in the study. Some 740 patients who underwent TP were matched with 1479 who had PD. After PSM, there was no difference between TP and PD groups regarding 30-day mortality (3.5% vs. 2.7%, p = 0.290) and 90-day mortality (9.9% vs. 8%, p = 0.135). More importantly, TP showed comparable survival in comparison to PD, prior or after excluding patients who died within 30 and 90 days. Besides, multivariate analysis revealed that tumor size, tumor stage, N stage, chemotherapy, and radiation were significant prognostic factors. CONCLUSION: PD and TP have similar early mortality and long-term survival for patients with PHAC. In selected patients, TP can be used when oncologically appropriate.
引用
- Zhu J, Jiang Z, Xie B, et al. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma. Surg Endosc. 2022. PMID: 35851818. doi:10.1007/s00464-022-09441-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。